Main Topic Area
All Topic Areas
1 - 10 of 1020 more >>
Articles
1 - 5 of 182 more >>
- Chagas disease
Chagas disease (also called American trypanosomiasis) is a mammalian disease occurring only in the Americas. It is caused by the protozoan Trypanosoma cruzi, one of the kinetoplastid flagellates, transmitted to humans by triatomine insects known in the different countries as assassin bug, vinchuca, kissing bug, chipo, barbeiro, etc. Common triatomine vector species for trypanosomiasis belong to the genera Triatoma, Rhodnius, and Panstrongylus. The most common transmitting species are Triatoma...
Wikipedia
- Alexander Disease Information Page
Alexander disease is a rare, genetically determined degenerative disorder of the central nervous system. It is one of a group of disorders known as the leukodystrophies, diseases that result from imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers in the brain. Myelin, which lends its color to the "white matter" of the brain, is a complex substance made up of at least ten different chemicals. Each of the leukodystrophies affects...
National Institute of Neurological Disorders and Stroke
- Alpers' Disease Information Page
Alpers' disease is a rare, genetically determined disease of the brain that causes progressive degeneration of grey matter in the cerebrum. The first sign of the disease usually begins early in life with convulsions. Other symptoms are developmental delay, progressive mental retardation, hypotonia (low muscle tone), spasticity (stiffness of the limbs), dementia, and liver conditions such as jaundice and cirrhosis that can lead to liver failure. Optic atrophy may also occur, often causing...
National Institute of Neurological Disorders and Stroke
- Alzheimer's Disease Information Page
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized in the brain by abnormal clumps (amyloid plaques) and tangled bundles of fibers (neurofibrillary tangles) composed of misplaced proteins. Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are...
National Institute of Neurological Disorders and Stroke
- Von Hippel-Lindau disease (VHL) Information Page
von Hippel-Lindau disease (VHL) is a rare, genetic multi-system disorder characterized by the abnormal growth of tumors in certain parts of the body (angiomatosis). The tumors of the central nervous system (CNS) are benign and are comprised of a nest of blood vessels and are called hemangioblastomas (or angiomas in the eye). Hemangioblastomas may develop in the brain, the retina of the eyes, and other areas of the nervous system. Other types of tumors develop in the adrenal glands, the kidneys,...
National Institute of Neurological Disorders and Stroke
Organizations
1 - 5 of 53 more >>
- Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion -
- Wilson's Disease Association - http://www.medhelp.org/wda/
- Olliers Disease Self-Help Group - http://www.ollier-maffucci.org/
- Parkinson's Disease Foundation - http://www.parkinsons-foundation.org/
- Celiac Disease Foundation - http://www.celiac.org/
News
1 - 5 of 8376 more >>
- Type 1 diabetes linked to pancreatic cancer risk
Reuters - Thu, 01 Mar 2007 05:24 EST
- Threshold Pharmaceuticals Announces That A Phase 3 Clinical Trial Of Glufosfamide For Treatment Of Pancreatic Cancer Did Not Meet Its Primary Endpoint
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
- First Evidence Of Stem Cells In Pancreatic Tumors
ScienceDaily - Mon, 12 Feb 2007 04:00 EST
- Gum Disease Associated With Pancreatic Cancer Risk
MedicalNewsToday - Mon, 22 Jan 2007 04:00 EST
- Periodontal Disease And Pancreatic Cancer Linked
MedicalNewsToday - Fri, 19 Jan 2007 05:00 EST
Clinical Trials
1 - 5 of 5223 more >>
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00064051 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005869 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00004003 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
- Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...

Not Signed In -

